 - Any unresolved toxicity Common Terminology Criteria for Adverse Events CTCAE grade 2 from previous anti-cancer therapy; subjects with irreversible toxicity that is not reasonably expected to be exacerbated by the investigational product may be included e.g., hearing loss, peripherally neuropathy 